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Abstract
Background/Aim. Lip, oral cavity and pharynx malignant
tumors account for 3.7% of all cancer deaths worldwide,
with significant geographic variations in frequency and
distribution. The aim of this descriptive epidemiologic study
was to analyze the mortality rate of lip, oral cavity and
pharynx malignant tumors in Serbia proper within a period
1991–2009. Methods. Mortality rates standardized directly
using the world population as the standard were used in
data analysis. Linear trend and regression analyses were used
to analyze rate trends in mortality. Results. The Serbian
population demonstrated an increase in the mortality of lip,
oral cavity and pharynx malignant tumors (y = 3.32 +
0.03×; p = 0.002; average annual percent change = + 0.8).
The male population showed a significant increase in
mortality trend (y = 5.90 + 0.03×; p = 0.020; % change =
+  0.9), while the female population did not show a
significant increase in mortality. The male/female cancer
mortality ratio was 5.5:1. Mortality rates for lip, oral cavity
and pharynx cancer increased with age in both genders, with
rates being the highest in the population aged 85 and older.
Increasing trends of lip, oral cavity and pharynx cancer
mortality were observed in males aged 50–54; the average
annual percent change was + 7.4 % (95% CI, 6.2–9.0). The
population of both genders aged 55–59 demonstrated an
increase in lip, oral cavity and pharynx cancer mortality, the
increase being + 1.8% (95% CI, 1.4–2.2) in men and +
34.3% (95% CI, 28.4–40.2) in women. Conclusion. The
increasing trend in lip, oral cavity and pharynx cancer
mortality points to the necessity to investigate etiology and
improve primary and secondary prevention measures.
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Apstrakt
Uvod/Cilj. Maligni tumori usne, usne duplje i ždrela uzrok su
3,7% svih smrtnih sluÿajeva od raka u svetu, sa znaÿajnim ge-
ografskim varijacijama u uÿestalosti i distribuciji. Cilj ove des-
kriptivne epidemiološke studije bila je analiza mortaliteta od
malignih tumora usne, usne duplje i ždrela u Srbiji u periodu
od 1991. do 2009. godine. Metode. U analizi podataka koriš-
ýene su standardizovane stope mortaliteta, dobijene metodom
direktne standardizacije sa populacijom sveta kao standardom.
Linearni trend i regresiona analiza korišýeni su za analizu tren-
da mortaliteta. Rezultati. U populaciji Srbije zabeležen je po-
rast mortaliteta od malignih tumora usne, usne duplje i ždrela
(y = 3,32 + 0,03×; p = 0,002; proseÿna godišnja procentualna
promena = + 0,8). Kod muškaraca je zabeležen znaÿajan
trend porasta mortaliteta (y = 5,90 + 0,03×;  p = 0,020;
% promena = + 0,9), dok kod žena nije utvrĀen znaÿajan po-
rast mortaliteta. Odnos mortaliteta meĀu polovima (muškar-
ci/žene) bio je 5,5 : 1. Stope mortaliteta od malignih tumora
usne, usne duplje i ždrela poveýavale su se sa starošýu kod oba
pola, pri ÿemu su stope bile najviše u populaciji starih od 85 i
više godina. Trend porasta mortaliteta od malignih tumora us-
ne, usne duplje i ždrela uoÿen je kod muškaraca starosti 50–54
godine: proseÿna godišnja procentualna promena iznosila je
+ 7,4% (95% IP = 6,2–9,0). U populaciji oba pola u uzrasnoj
grupi 55–59 godina zabeležen je trend porasta mortaliteta od
malignih tumora usne, usne duplje i ždrela, pri ÿemu je porast
iznosio + 1,8% (95% IP = 1,4–2,2) kod muškaraca i + 34,3%
(95% IP = 28,4–40,2) kod žena. Zakljuÿak. Trend porasta
mortaliteta od malignih tumora usne, usne duplje i ždrela uka-
zuje na neophodnost etioloških istraživanja i unapreĀenja me-
ra primarne i sekundarne prevencije.
Kljuÿne reÿi:
usta, neoplazme; farinks, neoplazme; srbija; mortalitet;
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Introduction
The International Association of Cancer Registries in
the most recent estimate reports 128,000 deaths from oral
cavity cancer (including lip cancer) and 147,000 pharyngeal
cancers in 2008 worldwide
 1–3. Oral cavity and pharynx can-
cers account for 3.7% of all cancer deaths in the world. Geo-
graphic variations in mortality were observed
 3–5.
Globally, the highest lip, oral cavity and pharynx cancer
mortality rates for both males and females are found in
Melanesia (11.3 per 100,000 people), South-Central Asia
(9.1), and South-East Asia (8.8) 
1, 3. The lowest death rates
are found in Central America (1.3), North America (1.5) and
Australia/New Zealand region (1.9). Nearly 80% of lip, oral
cavity and pharynx cancer cases (216,425 cases) occur in de-
veloping countries (150,820 men versus 65,605 women) 
1, 3.
The greatest number of deaths (70.1%) was recorded in Asia,
almost 50% of which occurred in India.
These cancers are more than twice as common in men
as in women
 5, 6. Most people of both genders, diagnosed
with oral cavity and pharynx cancer are older than 50 years
 5.
In the United States, from 1975 through 2002, age-adjusted
mortality rates were higher among males than females and
highest for black males
 7. By the mid 1980s, mortality rates
were declining for white and Afro-American males and fe-
males, but however disparities persist
 7, 8. In the United States
the lowest mortality rates were recorded in Latinos
 8. The
age-adjusted death rate for cancer of the oral cavity and
pharynx was 2.4 per 100,000 men and 0.7 per 100,000
women per year in 2005–2009 in the US Latinos, with a sig-
nificant declining trend (average annual percentage change
was – 3.6% in males and – 1.5 % in females). Though oral
and pharyngeal cancer mortality in Europe has declined in
the last decade in men, there are still rises in a few Central
and Eastern European countries, reaching exceedingly high
rates in Hungary and Slovakia, which now have the highest
rates on a European scale
 9, 10.
The aim of this descriptive epidemiologic analysis was
to estimate death rates for lip, oral cavity and pharynx cancer
and their secular trends in the population of Serbia over a pe-
riod 1991–2009.
Methods
This descriptive epidemiologic study used data on in-
dividuals who had died of lip, oral cavity and pharynx ma-
lignant tumors (codes 140–149 revision 9 and C00–C14 re-
vision 10 of the International Classification of Diseases to
classify death, injury and cause of death), all malignancies
(revision 9 codes 140–209 and revision 10 codes C00–
C97), symptoms and undefined states (revision 9 codes
780–799 and revision 10 codes R00–R99), and all causes of
death (revision 9 codes 001–999 and revision 10 codes
A00–Z99) collected by the Statistical Office of the
Republic of Serbia, which receives death certificates and
compiles mortality data by gender, age, year, and cause of
death. The research included the entire population of the
Republic of Serbia (all ages), excluding the Province of
Kosovo, from 1991 to 2009. Data for internally displaced
2009. Data for internally displaced persons and refugees
were included in the population of Serbia, but could not be
set aside as a special contingent. Data on the number and
composition of the population of the Republic of Serbia by
gender and age were obtained from the population censuses
(1991 and 2002 national censuses) for the years 1991 and
2002, and for inter-census years estimates published by the
Statistical Office of the Republic of Serbia. The age-
standardized rates (per 100,000 people per year) were cal-
culated by direct standardization, using the World Standard
Population as proposed by Jensen et al. 
11.
An estimate of the linear trend of the age-adjusted lip,
oral cavity and pharynx cancer mortality rates was obtained
by fitting Poisson regression models to the data observed
over the period 1991–2009. Two-sided p values were re-
ported and considered to indicate statistical significance
when they were less than 0.05. Age-specific mortality rates
were computed for 5-year age groups. Percent changes of
mortality rates were calculated as a percent difference be-
tween the adjusted rates of the two successive years and then
as an average of these changes for the entire observation pe-
riod. Confidence intervals (CI) for the average age specific
rates were assessed with 95% level of probability.
All statistical analyses were conducted using the Statis-
tical Package for the Social Sciences software (SPSS Inc,
version 19.0, Chicago, IL, USA).
Results
Over the 19-year observation period, in the Republic of
Serbia, excluding the Province of Kosovo, a significant de-
crease in total mortality was observed (y = 799.31 – 7.78×; p
= 0.000; % change = - 0.7), with a significant increase in
deaths from all malignant tumors (y = 119.69 + 1.18×; p =
0.000; % change = + 1.0) (Figure 1). Mortality rate of lip,
oral cavity and pharynx malignant tumors increased (y =
3.32 + 0.03×; p = 0.002; % change = + 0.8). The nonsignifi-
cant declining trend (y = 63.33 - 0.83×; p = 0.151; % change
= - 0.2) was observed for mortality in which the causes of
death were symptoms, signs and abnormal clinical and labo-
ratory findings.
In the same period, mortality of lip, oral cavity and
pharynx malignant tumors significantly increased among
males (y = 5.90 + 0.03×; p = 0.020; % change = + 0.9),
whereas the increase in mortality among women was not
statistically significant (Figure 2). On average, men died of
lip, oral cavity and pharynx malignant tumors 5.5 times more
frequently than women.
Trends analysis of age adjusted mortality rates of oral
cavity cancer (including lip cancer) showed a significant
increase (y = 1.79 + 0.02×; p = 0.001; % change = + 1.1)
in the population of Serbia (Figure 3), with an increase in
both genders (y = 3.20 + 0.03×; p = 0.010; % change = +
0.9 in men, versus y = 0.57 + 0.02×; p = 0.038; % change
= + 4.6 in women). On the other hand, mortality rates of
malignant pharyngeal tumors have not decreased signifi-
cantly (Figure 4).Volumen 70, Broj 2 VOJNOSANITETSKI PREGLED Strana 191
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Fig. 1 – The mortality rates of the choosen causes in Serbia, excluding the Province of Kosovo, in 1991–2009
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Fig. 2 – The mortality rates of malignant tumors of the lip, oral cavity and pharynx by gender in Serbia, excluding the
Province of Kosovo, in 1991–2009
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Fig. 3 – The mortality rates of malignant tumurs of the lip and oral cavity by gender in Serbia, excluding the Province of
Kosovo, in 1991–2009
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Fig. 4 – The mortality rates of malignant tumors of the pharynx by gender in Serbia, excluding the Province of Kosovo,
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Lip, oral cavity and pharynx cancer mortality rates in-
crease with age and are highest in people aged 85 and older
(Table 1). Low mortality rates were recorded in both men
and women aged under 45. In terms of gender, age-specific
rates were notably higher among males than among fe-
males, and the differences were highest for the age 45–64.
In the observation period, a significant increase in the
number of deaths caused by lip, oral cavity and pharynx
cancer was recorded in people aged 55–59, the increase
being + 1.8% (95% CI, 1.4–2.2) in men and + 34.3% (95%
CI, 28.4–40.2) in women. The male population also dem-
onstrated an increase of 7.4 % (95% CI, 6.2–9.0) in deaths
caused by lip, oral cavity and pharynx cancer in a younger
age group (50–54 years of age). None of the regression
analysis models corresponded to mortality data for other
age groups.
Discussion
Lip, oral cavity and pharynx cancer rates varied consid-
erably among countries
 2–4, 7. The highest standardized male
population death rates in 2008 were recorded in Hungary
(19.4 per 100,000 individuals), Slovakia (15.6) and India
(14.4), and the lowest mortality rates (approximately 1 per
100,000) are recorded in Israel, Kuwait and Cyprus
 2, 3.
Countries with female population mortality rates higher than
5 per 100,000 individuals are Bangladesh, Pakistan and In-
dia, and countries with the rates less than 1 per 100,000 indi-
viduals are countries of North and South America, Australia,
New Zealand and Northern and Western Europe.
In the period 1991–2009, the average standardized
mortality rate of lip, oral cavity and pharynx cancers in Ser-
bia was 6.2 per 100,000 in men and 1.2 per 100,000 in
women. These mortality rates place Serbia among the coun-
tries with medium mortality values. Serbian male and female
mortality rates are more similar to mortality rates of Central
and Western European countries rather than to those of East-
ern and South European countries
 3, 12.
In last decades, the USA records a decline in deaths of
oral cavity and pharynx cancers in all races (white, Afro-
American, Asian/Pacific Islander, American Indian/Alaska
Native, Latinos), for both sexes, although disparities per-
sist
 7, 8. Oral cancer mortality has been rising appreciably in
most European countries up to the late 1980s, essentially for
men
 6, 10. From 1990 to 2004, the European Union records a
decline in mortality of approximately 7% in men and an in-
Table 1
The average age-specific mortality rates and linear trend in lip, oral cavity and pharynx malignant tumors in Serbia,
excluding the Province of Kosovo, in 1991–2009
Age (years) Age-specific rates
*
(per 100,000) Linear trend p Average annual percentage
change (95% CI)
Male
 19 0.05 †
20–24 0.02 †
25–29 0.21 †
30–34 0.28 †
35–39 1.24 †
40–44 4.31 †
45–49 11.88 †
50–54 18.16 y = 15.04 + 0.31× 0.049 +7.4  (6.2–9.0)
55–59 25.82 y = 22.03 + 0.38× 0.003 +1.8 (1.4–2.2)
60–64 27.94 †
65–69 29.51 †
70–74 28.04 †
75–79 26.77 †
80–84 29.25 †
85+ 33.43 †
Female
 19 0.05 †
20–24 0.04 †
25–29 0.17 †
30–34 0.22 †
35–39 0.34 †
40–44 0.93 †
45–49 1.45 †
50–54 2.73 †
55–59 3.26 y = 0.56 + 0.95× 0.027 +34.3 (28.4–40.2)
60–64 3.74 †
65–69 4.44 †
70–74 6.51 †
75–79 9.09 †
80–84 13.86 †
85+ 20.56 †
† None of the regression analysis models corresponded to mortality data for this age group; CI í confidence intervalVolumen 70, Broj 2 VOJNOSANITETSKI PREGLED Strana 193
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crease of nearly 16% in women
 9, 13. However, in some
countries, such as Hungary, Romania, Slovakia and Czech
Republic, an increase in oral and pharynx cancer mortality in
both men and women is recorded. Oral cancer mortality in
men has been declining since the late 1980s in most western
countries, although some persisting upward trends were re-
corded in Denmark, United Kingdom, England and Wales,
and Scotland. These trends should be essentially interpreted
in terms of patterns and changes in exposure to alcohol and
tobacco in Central and Eastern Europe
 4, 9.
For the youngest age categories in the Serbian popula-
tion, mortality rates were generally less than 1 per 100,000
individuals per year; however, after about the third decade of
life, rates began to increase notably, with the sharpest in-
creases seen for males. Lip, oral cavity and pharynx cancer
mortality rates in 11 countries (USA, Asian and European
countries, and Australia) during the period 1990–2006, were
from 3 to 10 times higher in males than in females
 5. The rea-
son for this may be that men had been more likely to use to-
bacco and alcohol in the past
 4, 7, 10. Among females, few dif-
ferences in mortality rates were observed for all the countries
studied with the exception of China (Hong Kong)
 5. Although
the age-standardized rates in China (Hong Kong) have evi-
dently decreased over the period, they were still 5 times
higher for both genders.
Oral cavity cancer mortality rates ranged from 12.1 per
100,000 among males and 5.9 among females in Melanesia,
6.3 among males and 3.6 among females in South-Central
Asia, to less than 1 for both genders in North America,
Northern and Western Europe, and Australia/New Zea-
land
 1, 3. The highest pharyngeal cancer mortality rates in
2008 were recorded in South-Central Asia and Southern Af-
rica (7 per 100,000 among males and approximatively 2 per
100,000 among females). The lowest pharyngeal cancer
mortality rates (1 per 100,000) for both genders were re-
corded in North America, Northern and Western Europe, and
Australia/New Zealand. In India, among all malignant tu-
mors, lip, oral cavity and pharynx cancer mortality rates have
a leading position in the structure of mortality when consid-
ering the entire population (9.7 per 100,000) and the male
population alone (14.4), while they rank number 3 in female
population (5.4)
 1, 3. In India, pharyngeal cancer death was
more frequent than oral cavity cancer death in men (7.6 ver-
sus 6.8), while in women oral cavity cancer mortality rates
were twice as high as those of pharyngeal cancer.
Some potential explanations for this apparent differ-
ences among the countries may be discrepancies in the dis-
ease early detection and availability of the improved treat-
ment methods. However, numerous epidemiological studies
indicated that the increase was attributed primarily to
changes in the patterns of smoking and alcohol use (espe-
cially among women) in recent decades; in addition, nutri-
tional, lifestyle and other factors
 3, 14. The difference in rates
between black and white population is attributable to racial
differences in patterns of alcohol intake, especially among
current smokers, as well as to higher risks associated with
alcohol intake among blacks
 7, 10, 15. A Swedish population-
based case-control study showed that risk factors for oral
and oropharyngeal squamous cell carcinoma were poor oral
hygiene, dental status (defective and missing teeth), oral
mucosal lesions, alcohol and tobacco use, human papilloma
virus (HPV) infection, and lifestyle-related factors
 16. The
findings in England and Wales
 17 about a positive correla-
tion between liver cirrhosis and intraoral cancer suggested
that rising alcohol consumption is more closely related to
increasing intraoral cancer incidence and mortality than
smoking, most notably among younger males since the
early 1970s.
In India
 14, tobacco chewing emerged as the strongest
risk factor for oral cancer, while the strongest risk factor for
pharyngeal cancer was tobacco smoking in current smokers.
Oral tobacco products (snuff or chewing tobacco) are related
to cancers of the cheek, gums, and inner surface of the lips.
In Southeast Asia, South Asia, and some other areas of the
world, many people chew betel and/or gutka
 18, 19. Several
studies have found that a diet low in fruits and vegetables is
related to an increased risk of oral cavity and oropharyngeal
cancers
 20, 21.
The rising rate of HPV related cancers is thought to be
due to changes in sexual practices in recent decades, par-
ticularly to the increase in oral sex
 22. The International
Agency for Research on Cancer conducted a multicenter
case–control study of oral cavity and oropharyngeal cancer
in nine countries, where HPV DNA was detected in biopsy
specimens of 3.9% of oral cavity cancers with valid poly-
merase chain reaction (PCR) results and 18.3% of oropha-
ryngeal cancers 
23.
Mortality rates in the Republic of Serbia for which
symptoms, signs and ill-defined states were indicated as
causes of death suggest that caution must be present when
interpreting statistical data on mortality in international com-
parisons. However, it is not likely that these had a significant
impact on the increasing trend of lip, oral cavity and pharynx
cancer mortality, for which the increasing trend (y = 3.31 +
0.02; p = 0.033) was also observed for the 1991–2003 pe-
riod, when mortality rates of undefined death causes also
demonstrated a considerable increasing trend (y = 47.23 +
1.93; p = 0.000).
A similar increasing trend of the mortality of lip, oral
cavity and pharynx malignant tumors (average annual percent
change = + 0.8) and the mortality of all malignant tumors (av-
erage annual percent change = + 1.0) in Serbia can be only
partially explained by the lack of organized programs for pri-
mary and secondary prevention, especially during the recent
decades which characterised the economic sanctions against
Serbia, the war and the 1999 NATO bombing of Yugoslavia.
Other than, it was not possible to give specific information
about internally displaced persons and refugees, although they
may have a different exposure, which could be of great im-
portance for understanding the trends in mortality of malignant
tumors. Despite changes in recent years, the most significant
exposures to risk factors for malignant tumors in Serbia are
still higher than in developed countries. The prevalence of
smokers in the adult population has decreased from 40.5% in
2000 to 33.6% in 2006, while a third of young people in the
15–19 age group consumed alcoholic beverages
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an increase in the number of deaths of lip, oral cavity and
pharynx malignancies and of all malignant tumors  was ob-
served for the period from 1991 to 2009, is pointing to the
need to conduct analytical epidemiologic studies to help iden-
tify risk factors for lip, oral cavity and pharynx malignant tu-
mors in the Serbian population.
Conclusion
Lip, oral cavity and pharynx cancer mortality rates
place Serbia among the countries with medium mortality
values. The increasing trend in lip, oral cavity and pharynx
cancer mortality points to the necessity to investigate etiol-
ogy and improve primary and secondary prevention meas-
ures.
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